Aristo Bio-Tech and Lifescience (NSE:ARISTO) EPS (Basic): ₹5.97 (TTM As of Mar. 2025)


NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
60 GF Score
Price ₹99.70
! 2 Warning Signs
View Full Analysis

What is Aristo Bio-Tech and Lifescience EPS (Basic)?

Aristo Bio-Tech and Lifescience NSE:ARISTO 60 EPS (Basic) is ₹5.97 as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 60/100. The stock has 2 warning signs investors should review.

Aristo Bio-Tech and Lifescience's basic earnings per share (Basic EPS) for the six months ended in Mar. 2025 was ₹-0.72. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹5.97.

Aristo Bio-Tech and Lifescience's EPS (Diluted) for the six months ended in Mar. 2025 was ₹-0.72. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹5.97.

Aristo Bio-Tech and Lifescience's EPS without NRI for the six months ended in Mar. 2025 was ₹-0.72. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 5.97.

During the past 12 months, Aristo Bio-Tech and Lifescience's average EPS without NRIGrowth Rate was 4.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 23.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 35.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Aristo Bio-Tech and Lifescience's highest 3-Year average EPS without NRI Growth Rate was 65.60% per year. The lowest was 23.40% per year. And the median was 40.10% per year.

Aristo Bio-Tech and Lifescience  (NSE:ARISTO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Aristo Bio-Tech and Lifescience EPS (Basic) Related Terms

Aristo Bio-Tech and Lifescience EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience EPS (Basic) Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial 1.58 2.11 6.72 5.72 5.97

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only 1.46 3.78 1.94 6.69 -0.72
NSE:ARISTO
60GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aristo Bio-Tech and Lifescience EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aristo Bio-Tech and Lifescience's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(40.631-0)/6.808
=5.97

Aristo Bio-Tech and Lifescience's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-4.903-0)/6.809
=-0.72

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹5.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹5.97 mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a EPS (Basic) of ₹5.97 as of Mar. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aristo Bio-Tech and Lifescience and its competitors.
Is Aristo Bio-Tech and Lifescience's EPS (Basic) too high?
Aristo Bio-Tech and Lifescience's current EPS (Basic) is ₹5.97. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's EPS (Basic) compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's EPS (Basic) of ₹5.97 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for an Agriculture company?
A good EPS (Basic) depends on the Agriculture industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aristo Bio-Tech and Lifescience and its competitors. Aristo Bio-Tech and Lifescience's current EPS (Basic) is ₹5.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current EPS (Basic) of ₹5.97. The current EPS (Basic) is ₹5.97. Aristo Bio-Tech and Lifescience's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current EPS (Basic) is ₹5.97 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
60GF Score

Get the complete analysis for NSE:ARISTO

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹99.70
Price